GANDOLFO, Federico
GANDOLFO, Federico
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
2018-01-01 Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S.; Nobili, F.; Frisoni, G. B.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Walker, Z.
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
2018-01-01 Walker, Z.; Gandolfo, F.; Orini, S.; Garibotto, V.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Boccardi, M.; Altomare, D.; Festari, C.; Nobili, F.
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
2018-01-01 Agosta, F.; Altomare, D.; Festari, C.; Orini, S.; Gandolfo, F.; Boccardi, M.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Pagani, M.
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
2018-01-01 Bouwman, F.; Orini, S.; Gandolfo, F.; Altomare, D.; Festari, C.; Agosta, F.; Arbizu, J.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Morbelli, S.; Boccardi, M.
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus
2018-01-01 Nobili, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Agosta, F.; Nestor, P.; Walker, Z.; Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia | 1-gen-2018 | Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S.; Nobili, F.; Frisoni, G. B.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Walker, Z. | |
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia | 1-gen-2018 | Walker, Z.; Gandolfo, F.; Orini, S.; Garibotto, V.; Agosta, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Boccardi, M.; Altomare, D.; Festari, C.; Nobili, F. | |
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease | 1-gen-2018 | Agosta, F.; Altomare, D.; Festari, C.; Orini, S.; Gandolfo, F.; Boccardi, M.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Pagani, M. | |
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia | 1-gen-2018 | Bouwman, F.; Orini, S.; Gandolfo, F.; Altomare, D.; Festari, C.; Agosta, F.; Arbizu, J.; Drzezga, A.; Nestor, P.; Nobili, F.; Walker, Z.; Morbelli, S.; Boccardi, M. | |
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus | 1-gen-2018 | Nobili, F.; Arbizu, J.; Bouwman, F.; Drzezga, A.; Agosta, F.; Nestor, P.; Walker, Z.; Boccardi, M.; Festari, C.; Altomare, D.; Gandolfo, F.; Orini, S. |